Comparisons between ticagrelor and clopidogrel following percutaneous coronary intervention in patients with acute coronary syndrome: a comprehensive meta-analysis

References

• GoldbergRJSpencerFAGoreJMLessardDYarzebskiJThirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspectiveCirculation200911991211121919237658
   PubMed Web of Science ®Google Scholar
• O’GaraPTKushnerFGAscheimDDFoundation/American Heart Association Task Force on Practice Guidelines2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of cardiology Foundation/American Heart Association Task Force on practice guidelinesJ Am Coll Cardiol2013614e78e14023256914
   PubMed Web of Science ®Google Scholar
• NeumannFJSousa-UvaMAhlssonAESC Scientific Document GroupESC/EACTS guidelines on myocardial revascularizationEur Heart J2018252018
   Google Scholar
• CowleyMJKuritzkyLDevelopments in antiplatelet therapy for acute coronary syndromes and considerations for long-term managementCurr Med Res Opin20092561477149019419337
   PubMed Web of Science ®Google Scholar
• GroveELWürtzMThomasMRKristensenSDAntiplatelet therapy in acute coronary syndromesExpert Opin Pharmacother201516142133214726293612
   PubMed Web of Science ®Google Scholar
• ParodiGMarcucciRValentiRHigh residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCIJAMA2011306111215122321934054
   PubMed Web of Science ®Google Scholar
• StoreyRFHustedSHarringtonRAInhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromesJ Am Coll Cardiol200750191852185617980251
   PubMed Web of Science ®Google Scholar
• HustedSEmanuelssonHHeptinstallSSandsetPMWickensMPetersGPharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirinEur Heart J20062791038104716476694
   PubMed Web of Science ®Google Scholar
• WallentinLBeckerRCBudajADISPERSE-2 InvestigatorsTicagrelor versus clopidogrel in patients with acute coronary syndromesN Engl J Med2009361111045105719717846
   PubMed Web of Science ®Google Scholar
• CannonCPHustedSHarringtonRASafety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non–st-segment elevation acute coronary syndromeJ Am Coll Cardiol200750191844185117980250
   PubMed Web of Science ®Google Scholar
• GotoSHuangCHParkSJEmanuelssonHKimuraTTicagrelor vs. Clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome–randomized, double-blind, Phase III PHILO studyCirc J201579112452246026376600
   PubMed Web of Science ®Google Scholar
• ZoccaPvan der HeijdenLCKokMMClopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: change DAPTEuro Intervention201713101168117629151439
   PubMed Web of Science ®Google Scholar
• ParkKHJeongMHAhnYKAMIR-NIH registry investigatorsComparison of short-term clinical outcomes between ticagrelor versus clopidogrel in patients with acute myocardial infarction undergoing successful revascularization; from Korea acute myocardial infarction Registry – National Institute of healthInt J Cardiol201621519320027128530
   PubMed Web of Science ®Google Scholar
• GuanWLuHYangKChoosing between ticagrelor and clopidogrel following percutaneous coronary intervention: a systematic review and meta-analysis (2007–2017)Medicine (Baltimore)20189743e1297830412125
   PubMed Web of Science ®Google Scholar
• BonelloLLaineMLemesleGMeta-analysis of potent P2Y12-ADP receptor antagonist therapy compared to clopidogrel therapy in acute coronary syndrome patients with chronic kidney diseaseThromb Haemost2018118101839184630235475
   PubMed Web of Science ®Google Scholar
• JadadARMooreRACarrollDAssessing the quality of reports of randomized clinical trials: is blinding necessary?Control Clin Trials19961711128721797
   PubMedGoogle Scholar
• Biondi-ZoccaiGGAbbateAAgostoniPLong-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: a metaregressionAm Heart J2005149350451115864240
   PubMed Web of Science ®Google Scholar
• RenQRenCLiuXDongCZhangXTicagrelor vs. clopidogrel in non-ST-elevation acute coronary syndromesHerz201641324624926525521
   PubMed Web of Science ®Google Scholar
• WangHYLiYXuXMLiJHanYLImpact of baseline bleeding risk on efficacy and safety of ticagrelor versus clopidogrel in Chinese patients with acute coronary syndrome undergoing percutaneous coronary interventionChin Med J (Engl)2018131172017202430127210
   PubMed Web of Science ®Google Scholar
• MauriLHsiehWHMassaroJMHoKKD’AgostinoRCutlipDEStent thrombosis in randomized clinical trials of drug-eluting stentsN Engl J Med2007356101020102917296821
   PubMed Web of Science ®Google Scholar
• LiberatiAAltmanDGTetzlaffJThe PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaborationBMJ2009339b270019622552
   PubMed Web of Science ®Google Scholar
• EggerMDavey SmithGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
   PubMed Web of Science ®Google Scholar
• WangHWangXEfficacy and safety outcomes of ticagrelor compared with clopidogrel in elderly Chinese patients with acute coronary syndromeTher Clin Risk Manag2016121101110527471389
   PubMed Web of Science ®Google Scholar
• TangXLiRJingQAssessment of ticagrelor versus clopidogrel treatment in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary interventionJ Cardiovasc Pharmacol201668211512027010809
   PubMed Web of Science ®Google Scholar
• ChenICLeeCHFangCCEfficacy and safety of ticagrelor versus clopidogrel in acute coronary syndrome in Taiwan: a multicenter retrospective pilot studyJ Chin Med Assoc2016791052153027339180
   PubMed Web of Science ®Google Scholar
• VercellinoMSànchezFABoasiVTicagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysisBMC Cardiovasc Disord20171719728381298
   PubMed Web of Science ®Google Scholar
• PriceMJBergerPBTeirsteinPSStandard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trialJAMA2011305111097110521406646
   PubMed Web of Science ®Google Scholar
• GurbelPAErlingeDOhmanEMPlatelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the trilogy ACS platelet function substudyJAMA2012308171785179423117779
   PubMed Web of Science ®Google Scholar
• FanZGDingGBLiXBGaoXFGaoYLTianNLThe clinical outcomes of triple antiplatelet therapy versus dual antiplatelet therapy for high-risk patients after coronary stent implantation: a meta-analysis of 11 clinical trials and 9,553 patientsDrug Des Devel Ther20161034353448
   PubMed Web of Science ®Google Scholar
• BirkelandKParraDRosensteinRAntiplatelet therapy in acute coronary syndromes: focus on ticagrelorJ Blood Med2010119721922282698
   PubMedGoogle Scholar
• ConeJWangSTandonNComparison of the effects of cilostazol and milrinone on intracellular cAMP levels and cellular function in platelets and cardiac cellsJ Cardiovasc Pharmacol199934449750410511123
   PubMed Web of Science ®Google Scholar
• ValgimigliMGagnorACalabróPMATRIX InvestigatorsRadial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trialLancet201538599862465247625791214
   PubMed Web of Science ®Google Scholar